SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Mylan Labs
MYL 15.860.0%Nov 19 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Christopher Nicora who wrote (269)4/6/1998 6:35:00 PM
From: J.K.B.  Read Replies (1) of 384
 
C. N.

I got real interested in MYLAN whenever the purchased the raw material for several generic drugs. They became the sole provider. But recently one of my pharmacies in Arkansas sent me a copy of a letter sent to them from PAY (Pharmacy Associates Inc.). The letter stated that they would be removing MYLAN from their formulary. Until they changed their pricing. This in itself is not all that interesting unless other insurance companies follow suit. This is just a thought. Proceed with caution. Just some friendly notes.

Some other interesting stocks that I have found are QTNT ~175,000 float with ~7,000,000 outstanding shares, and AIMH is working a deal with GM float ~1,000,000. It is also my understanding that ~500,00 of that is on short calls. With a little movement this thing could snowball.
Just a little note.
J.K.B.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext